The Health Care Select Sector SPDR® Fund Newsroom

Johnson & Johnson Analyst Ratings

Benzinga13:04 ET

AbbVie Analyst Ratings

BenzingaJul 19 10:42 ET

BMO Capital Adjusts Price Target on Merck to $150 From $148

MT NewswiresJul 19 09:19 ET

Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)

TipRanksJul 19 08:59 ET

HSBC Adjusts Price Target on Johnson & Johnson to $174 From $170, Maintains Buy Rating

MT NewswiresJul 19 08:47 ET

Jefferies Adjusts Price Target on Amgen to $380 From $375

MT NewswiresJul 19 08:41 ET

HSBC Raises Price Target on Eli Lilly to $1,100 From $880, Maintains Buy Rating

MT NewswiresJul 19 08:25 ET

Nephron Adjusts Price Target on Abbott Laboratories to $110 From $115

MT NewswiresJul 19 07:43 ET

Deutsche Bank Raises Price Target on UnitedHealth Group to $632 From $562, Keeps Buy Rating

MT NewswiresJul 19 07:24 ET

Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects

TipRanksJul 19 06:14 ET

Buy Rating Affirmed on Abbott Laboratories Amid Strong Q2 Results and Raised 2024 Guidance

TipRanksJul 18 16:21 ET

UnitedHealth Group Analyst Ratings

BenzingaJul 18 13:03 ET

UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating

MT NewswiresJul 18 11:03 ET

RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target

BenzingaJul 18 10:40 ET

Elevance Extends Losses as BofA Cuts on Medicaid Headwinds

Seeking AlphaJul 18 10:27 ET

Buy Rating Affirmed for Abbott Laboratories Amid Strong Financials and Growth Potential

TipRanksJul 18 09:18 ET

Johnson & Johnson (JNJ) Gets a Buy From RBC Capital

TipRanksJul 18 06:41 ET

Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating

MT NewswiresJul 18 05:38 ET

Johnson & Johnson Analyst Ratings

BenzingaJul 18 05:28 ET

UnitedHealth's Strong Q2 Performance and Strategic Initiatives Secure Buy Rating

TipRanksJul 18 02:52 ET